Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Pinnacle Discovers Silver-Lead-Zinc Mineralization Following up on LiDAR Survey at El Potrero (click to learn more) Sekur Private Data Signs Distribution Agreement In Africa (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Akari Therapeutics PLC AKTX

Healthcare Biotechnology
Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company’s lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2... see more

Current News (NDAQ:AKTX)

Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala

GlobeNewswire 4 days ago

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

GlobeNewswire February 26, 2026

Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

GlobeNewswire February 23, 2026

Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference

GlobeNewswire February 18, 2026

Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing the Company's Expanded ADC Pipeline

GlobeNewswire February 11, 2026

Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

GlobeNewswire February 5, 2026

Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors

GlobeNewswire January 26, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

GlobeNewswire January 9, 2026

Akari Therapeutics to Present at the 2026 Biotech Showcase

GlobeNewswire January 8, 2026
View More News ››

Opinion & Analysis (NDAQ:AKTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AKTX)

Excellent YT coverage on Akari!

https://youtu.be/KTwztpoUB1I?si=mRfnI9EC3bYyiNxt
BryceCanada - November 6, 2023

RE:Rumour Mill Whispers..

http://investor.akaritx.com/static-files/50c90eba-430c-4e52-b500-9462bb00ada8
InsideTweeter - December 11, 2021

Rumour Mill Whispers..

Watch this..!!  Market cap $75M - Robust Pipeline - Acquisition value of similar companies in complement space with similar...
InsideTweeter - December 11, 2021

it's a buy today for me

at $4.25 per share,so glta.
coolfooldumbguy - April 23, 2019

it's a sell today for me

I am too busy day trading stocks right now,so glta but there is no time for me to post all of my buy & sells anymore for you guys.
coolfooldumbguy - March 14, 2019

RE:Been strong all day..............

YYEEEHHHAAA.............$ 11.20 high ......15 minutes to the close.!!!!!!!!!!!!!! SSSSSSAAAAAWWWWWEEEETTTT !!!!!!!!!!!!!!!!!!!!!!!!
Iseneschal - March 31, 2017
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas in ...
View More »

Podcasts